MET
58
2
MHK
25
5
IR
46
3
ORLY
48
3
L
54
5
AA
27
5
PM
49
8
PSA
43
6
SPG
45
2
MRK
25
2
BIIB
36
8
JWN
72
9
FCX
44
4
OKE
61
2
WHR
61
3
XOM
33
3
USB
50
3
CHD
34
7
AMT
30
2
CHRW
53
2
MET
58
2
MHK
25
5
IR
46
3
ORLY
48
3
L
54
5
AA
27
5
PM
49
8
PSA
43
6
SPG
45
2
MRK
25
2
BIIB
36
8
JWN
72
9
FCX
44
4
OKE
61
2
WHR
61
3
XOM
33
3
USB
50
3
CHD
34
7
AMT
30
2
CHRW
53
2
Financhill
Back

Guardant Health 10K Form

Sell
38

GH
Guardant Health

Last Price:
$31.23
Seasonality Move:
10%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GH News And Ratings

See the #1 stock for the next 7 days that we like better than GH

GH Financial Statistics

Sales & Book Value

Annual Sales: $563.9M
Cash Flow: $-55.3M
Price / Cash Flow: 0
Annual Sales: $-0.49
Price / Book: 28.68

Profitability

EPS (TTM): -4.24000
Net Income (TTM): $-512.4M
Gross Margin: $336.9M
Return on Equity: -651%
Return on Assets: -30.37%

Guardant Health Earnings Forecast

Key Guardant Health Financial Ratios

  • The Gross Profit Margin over the past 8 years for GH is 59.74%.
  • The Selling, General & Administrative Expenses for GH have been equal to 79.98% of Gross Profit Margin.
  • The Research & Development expenses have been 65.11% of Revenue.
  • The Interest Expense is -0.54% of Operating Income.
  • The Net Earning history of GH is -85.02% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Guardant Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: GH
CUSIP: 40131M
Website: guardanthealth.com

Debt

Debt-to-Equity Ratio: -19
Current Ratio: 6.22
Quick Ratio: 5.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GH Technical Analysis vs Fundamental Analysis

Sell
38
Guardant Health (GH) is a Sell

Is Guardant Health a Buy or a Sell?

  • Guardant Health stock is rated a Sell
    The current Guardant Health [GH] share price is $31.65. The Score for GH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.